- DBS’ 3Q25 results beat estimates on robust non-II performance.
- Looking ahead to 2026, DBS guided for PATMI to be slightly below 2025 levels. However, it reaffirmed its commitment to continue with its capital return dividend in 2026. This, coupled with the 24-cent step-up in ordinary dividend, would translate to 2026F dividend growth of 6% and FY26F yield of 6%.
3Q25 results beat expectations.
- - Read this at SGinvestors.io -
- 9M25 ROE was 17% (FY24: 18%) while the fully phased-in CET-1 ratio under Basel III reforms was stable q-o-q at a solid 15.1%.
- - Read this at SGinvestors.io -
Results highlights.
- Read more at SGinvestors.io.
Above is an excerpt from a report by RHB Securities Research.
Clients of RHB may be the first to access the full PDF report @ https://www.rhbtradesmart.com/.
Singapore Research RHB Securities Research | https://www.rhbgroup.com/ 2025-11-07
Read also RHB's most recent report:
2026-07-14 DBS - Expecting Resiliency For Upcoming 2Q26 Results; BUY.
Previous report by RHB:
2026-05-28 DBS - A Core Holding For SG Bank Investors; Stay BUY.
Price targets by 4 other brokers at DBS Target Prices.
Listing of research reports at DBS Analyst Reports.
Relevant links:
DBS Share Price History,
DBS Announcements,
DBS Dividend Payout Dates & Corporate Actions,
DBS News
